Back to search

Article

Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCA

2023-11-25

Abstract excerpt

<h4>Background: </h4> Bladder cancer is a common malignancy of the urinary system, and the survival rate and recurrence rate of patients with muscular aggressive (MIBC) bladder cancer are not ideal. Hypoxia is a pathological process in which cells acquire special characteristics to adapt to anoxic environment, which can directly affect the proliferation, invasion and immune response of bladder cancer cells. Unders...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd01b3e6-e363-5de2-be8d-b62754bd6c86
DOI
10.21203/rs.3.rs-3640530/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in BLCADOI 10.21203/rs.3.rs-3640530/v1
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancerSemantic proximity
Identification of hypoxia- and immune- based prognostic signature and validation of TFRC as a potential biomarker and therapeutic target in bladder cancerSemantic proximity
Identification and Validation of A Hypoxia-Related Prognostic and Immune Microenvironment Signature in Bladder CancerSemantic proximity
Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancerSemantic proximity
Hypoxia score for predicting prognosis and tumor response to immunotherapy in bladder urothelial carcinomaSemantic proximity
New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity
Integrative analysis of immune molecular subtypes and microenvironment characteristics of bladder cancer.Semantic proximity
A comprehensive analysis of the significance of immunogenic cell death-related genes in the prognosis and immune microenvironment of patients with bladder cancerSemantic proximity
Development of A Prognostic Index and Screening of Prognosis Related Genes Based on an Immunogenomic Landscape Analysis of Bladder CancerSemantic proximity
Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancerSemantic proximity
Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progressionSemantic proximity
Risk stratification based on immune signature and prediction of immune checkpoint inhibitor’s efficacy for bladder urothelial carcinomaSemantic proximity
Select a neighboring publication to make it the new centre.